Ultralife (NASDAQ:ULBI) Posts Earnings Results, Misses Expectations By $0.09 EPS

Ultralife (NASDAQ:ULBI – Get Free Report) released its quarterly earnings data on Thursday. The technology company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.09), FiscalAI reports. Ultralife had a negative net margin of 3.50% and a positive return on equity of 2.75%. The company had revenue of $48.27 million during the quarter, compared to analyst estimates of $56.00 million.

Ultralife Trading Up 0.1%

Shares of ULBI stock traded up $0.01 during trading hours on Thursday, reaching $15.63. The company had a trading volume of 242,421 shares, compared to its average volume of 65,842. Ultralife has a 1-year low of $4.90 and a 1-year high of $15.69. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.87 and a quick ratio of 1.30. The firm has a market cap of $260.40 million, a price-to-earnings ratio of -39.08 and a beta of 0.63. The company has a 50 day moving average of $7.24 and a 200 day moving average of $6.60.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Ultralife in a research note on Wednesday, September 9th. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, the company currently has an average rating of “Sell”.

Check Out Our Latest Research Report on Ultralife

Ultralife Company Profile

(Get Free Report)

Ultralife Corporation is a New York-based manufacturer of power and communications products serving government, defense, aerospace, industrial, medical and other specialized markets. The company develops and produces batteries, battery packs, chargers and related power-management products designed for portable and mission-critical equipment.

Ultralife’s product portfolio includes lithium primary and rechargeable batteries, custom battery assemblies, military battery systems, charging equipment and accessories.

Featured Stories

Earnings History for Ultralife (NASDAQ:ULBI)

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.